|
crispr |
7 |
|
high-throughput screening |
5 |
|
combigem |
4 |
|
crispr screen |
4 |
|
protein engineering |
4 |
|
acyltransferases - metabolism |
3 |
|
acyltransferases, 2.3.- |
3 |
|
animals |
3 |
|
autophagy |
3 |
|
cancer neuroscience |
3 |
|
cdk5 protein, mouse, 2.7.1.37 |
3 |
|
chemicals and cas registry numbers: 2-acylglycerophosphate acyltransferase, 2.3.1.52 |
3 |
|
cholesterol |
3 |
|
coculture |
3 |
|
combination therapy |
3 |
|
combinatorial genetics |
3 |
|
combinatorial mutagenesis |
3 |
|
cyclin-dependent kinase 5 - chemistry - metabolism |
3 |
|
cyclin-dependent kinase 5 - deficiency - metabolism |
3 |
|
cyclin-dependent kinase 5, 2.7.11.22 |
3 |
|
disease models, animal |
3 |
|
enteric neuron |
3 |
|
fatty acid |
3 |
|
gastric cancer |
3 |
|
genome editing |
3 |
|
lipid metabolism |
3 |
|
long-term potentiation - drug effects - genetics - physiology |
3 |
|
machine learning |
3 |
|
memory - physiology |
3 |
|
mice |
3 |
|
organoid |
3 |
|
parkinson disease - metabolism - pathology |
3 |
|
phosphorylation |
3 |
|
protein binding |
3 |
|
receptor, trkb - genetics - metabolism |
3 |
|
spatial behavior - physiology |
3 |
|
tumor vulnerability |
3 |
|
active learning |
2 |
|
base editor |
2 |
|
cas9 |
2 |
|
combinatorial assembly |
2 |
|
combiseal |
2 |
|
endothelial cells |
2 |
|
escs |
2 |
|
humans |
2 |
|
immune tolerance |
2 |
|
inflammation - physiopathology |
2 |
|
low-n |
2 |
|
neoplasms - physiopathology |
2 |
|
neurodegenerative diseases - physiopathology |
2 |
|
phagocytosis |
2 |
|
species index: mammalia |
2 |
|
xenotransplantation |
2 |
|
zero-shot |
2 |
|
alphafold |
1 |
|
base editing |
1 |
|
base sequence |
1 |
|
biomarkers, tumor |
1 |
|
cd9 |
1 |
|
cell line, tumor |
1 |
|
cell-surface marker |
1 |
|
combinatorial chemistry techniques |
1 |
|
combinatorial genetics en masse |
1 |
|
crispr-cas |
1 |
|
crispr/cas |
1 |
|
deaminase |
1 |
|
deep learning |
1 |
|
druggable targets |
1 |
|
editing outcome |
1 |
|
energy and contact changes |
1 |
|
functional genomics |
1 |
|
genes |
1 |
|
genetic markers |
1 |
|
genetic perturbations |
1 |
|
genome |
1 |
|
guide rna scaffold |
1 |
|
high throughput screening |
1 |
|
human pluripotent stem cells |
1 |
|
multifactorial genetics |
1 |
|
multiplexed genetic perturbations |
1 |
|
multiplexed genome editing |
1 |
|
pancreatic β cells |
1 |
|
precise genome editing |
1 |
|
precise genome editor |
1 |
|
precision therapy |
1 |
|
protein structure modeling |
1 |
|
protein-nucleic acid interaction |
1 |
|
rosetta |
1 |
|
sgrna performance prediction |
1 |
|
single guide |
1 |
|
single-cell transcriptomics |
1 |
|
spcas9 optimization |
1 |
|
synthetic biology |
1 |
|
systems biology |
1 |
